Novartis India Ltd (NOVARTIND)

NSE · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

₹1,692.40

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹1,692.40 on 30 Oct 2026. The share price traded between ₹950.00 and ₹2,588.80 (intraday) since listing on 20 Apr 2026.

The closes as a table

DateClose

Key figures

Range since listing on 20 Apr 2026 (intraday)

Last close ₹1,692.40

Low ₹950.00High ₹2,588.80

Market cap₹4,062 crorelast close × shares
P/E42.7on reported profit, last four quarters
Net profit₹98.00 crlast 12 months
Return on equity11.6%year to Mar 2026
EBITDA margin27%year to Mar 2026
Debt to equity0.0037year to Mar 2026
Net margin26.3%year to Mar 2026
Dividend yieldnonelast 12 months

Price trend

Revenue and profit

RevenueNet profit₹ crore
-2000200400
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue400379335356354
Net profit-41038510193
EBITDA margin7%17%19%26%27%
Borrowings2422753

₹ crore. Over three years, compounded: revenue fell 2.2% a year, net profit fell 3.3% a year.

Recent filings

Questions about Novartis India Ltd

What is Novartis India Ltd's market value?

Novartis India Ltd's market value is ₹4,062 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 42.7, the last close over earnings per share for the last four reported quarters.

Go further with NOVARTIND

Free to start: test a trading idea on NOVARTIND's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceuticals), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.